Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

NCT03937635

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 747 locations
View Trial Details
Recruiting

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

NCT03113643

Conditions
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

NCT07231952

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Dana Farber Cancer Institute (Data Collection and Specimen Analysis) Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details
Recruiting

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

NCT06788756

Conditions
Acute Myeloid Leukaemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Bioresearch Partners Miami, Florida, United States
  • Augusta University - Georgia Cancer Center Augusta, Georgia, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Atlantic Health Morristown, New Jersey, United States
View all 25 locations
View Trial Details

Related conditions